Company intelligence / Profile preview

Shenzhen Zijian Biotechnology

Shenzhen, Guangdong, Chinaszzijian.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Shenzhen Zijian Biotechnology has developed nearly 200 detection kits across molecular diagnostics and immunodiagnostics. Many products have obtained NMPA (China FDA), CE Marking, and some FDA certifications. Their solutions are used globally in hospitals and public health institutions for rapid and accurate disease detection. No specific clinical trial results are reported as the company focuses on diagnostic devices rather than therapeutics.

Therapeutic areas: OtherPulmonologyHematologyInfectious Diseases
Modalities: Fluorescence ImmunoassayMolecular DiagnosticsRapid Test (Lateral Flow)Biochemistry AnalyzerHematology Analyzer
Industry: Molecular Diagnostics

Partnerships

EUROIMMUNMindrayThermo Fisher ScientificPerkinElmerTECAN

Beyond the preview

Go deeper on Shenzhen Zijian Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhen Zijian Biotechnology.

Explore the full profile